EMA
guidance
· 2017-10-30
How to develop vaccines and medicines that prevent and treat respiratory syncytial virus (RSV) infection
Summary
EMA guidance outlining considerations for developing vaccines and medicines to prevent and treat respiratory syncytial virus (RSV) infection.
Upgrade for the full analysis, importance score, and drug timeline.